Sensitizing effects of an organovanadium compound during adjuvant therapy with cyclophosphamide in a murine tumor model.
Biomed Pharmacother
; 93: 816-829, 2017 Sep.
Article
in En
| MEDLINE
| ID: mdl-28711021
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Vanadium Compounds
/
Cyclophosphamide
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Year:
2017
Type:
Article